Evidence map›Paper›PMID 31555480›Full record

ArticleJournal of 3D printing in medicine2019

Use of GelMA for 3D printing of cardiac myocytes and fibroblasts.

Priyanka Koti, Narine Muselimyan, Eman Mirdamadi, Huda Asfour, Narine A Sarvazyan

Abstract read
In one paragraph

Article in Journal of 3D printing in medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. 3D Bioprinting Functional Engineered Heart Tissues.International journal of molecular sciences · 2025
    Review
  8. Stimuli-responsive hybrid materials for 4DMaterials today. Bio · 2025
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Designing a 3D Printing Based Auxetic Cardiac Patch with hiPSC-CMs for Heart Repair.Journal of cardiovascular development and disease · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Priyanka KotiDepartment of Pharmacology & Physiology, The George Washington University School of Medicine & Health Sciences, 2300 I-street, Ross Hall 454, Washington DC 20037, USA.
Narine MuselimyanDepartment of Pharmacology & Physiology, The George Washington University School of Medicine & Health Sciences, 2300 I-street, Ross Hall 454, Washington DC 20037, USA.
Eman MirdamadiDepartment of Pharmacology & Physiology, The George Washington University School of Medicine & Health Sciences, 2300 I-street, Ross Hall 454, Washington DC 20037, USA.
Huda AsfourDepartment of Pharmacology & Physiology, The George Washington University School of Medicine & Health Sciences, 2300 I-street, Ross Hall 454, Washington DC 20037, USA.
Narine A SarvazyanDepartment of Pharmacology & Physiology, The George Washington University School of Medicine & Health Sciences, 2300 I-street, Ross Hall 454, Washington DC 20037, USA.
George Washington University · USGTx (United States) · US

Funding

Cardiomyocyte-derived Venous Assist Device: Aiding peripheral blood flowR21HL122882 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI SARVAZYAN, NARINE · 2015 to 2016
$432k
American Heart Association-American Stroke Association 14GRNT20380806NHLBI NIH HHS R21 HL122882
6 · The paper itself

Abstract

aimTo 3D print heart tissue, one must understand how the main two types of cardiac cells are affected by the printing process. MATERIALS &

methodsEffects of gelatin methacryloyl (GelMA) concentration, extruder pressure and duration of UV exposure on survival of cardiac myocytes and fibroblasts were examined using lactate dehydrogenase and LIVE/DEAD assays, bioluminescence imaging and morphological assessment. RESULTS &

conclusionCell survival within 3D printed cardiomyocyte-laden GelMA constructs was more sensitive to extruder pressure and GelMA concentrations than within 3D fibroblast-laden GelMA constructs. Cells within both types of constructs were adversely impacted by the UV curing step. Use of mixed cell populations and enrichment of bioink formulation with fibronectin led to an improvement of cardiomyocyte survival and spreading.

Indexed as

3D bioprintingbioluminescence imagingcardiac fibroblastscardiomyocytescell viabilityGelMA

Identifiers

PMID31555480
PMCPMC6760315
OpenAlexW2911218767

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.